Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The Use of Topical Hemostatic Agents in Cardiothoracic Surgery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Exploring Shared Mental Models of surgical teams in Video-Assisted Thoracoscopic Surgery lobectomy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Important Non-Technical Skills in Video-Assisted Thoracoscopic Surgery Lobectomy: Team Perspectives

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Endocarditis in a Quadricuspid Aortic Valve

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Transcatheter Pulmonary Valve Replacement for Right Ventricular Outflow Tract Conduit Dysfunction After the Ross Procedure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A national center for persistent severe pain after groin hernia repair: Five-year prospective data

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Temporal trends in length of stay and readmissions after fast-track hip and knee arthroplasty

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Art Bracey
  • Aryeh Shander
  • Solomon Aronson
  • Bradley A Boucher
  • Domenico Calcaterra
  • Michael W A Chu
  • Richard Culbertson
  • Karim Jabr
  • Henrik Kehlet
  • Omar Lattouf
  • S Chris Malaisrie
  • C David Mazer
  • Martin M Oberhoffer
  • Sherri Ozawa
  • Theolyn Price
  • Todd Rosengart
  • Bruce D Spiess
  • Giuseppe Turchetti
Vis graf over relationer

Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.

OriginalsprogEngelsk
TidsskriftThe Annals of thoracic surgery
Vol/bind104
Udgave nummer1
Sider (fra-til)353-360
Antal sider8
ISSN0003-4975
DOI
StatusUdgivet - 24 apr. 2017

ID: 50559096